Venture Capital
Drug discovery startup Jnana Therapeutics has come out of stealth mode with $50 million in funding that it plans to use to search for new drugs that target proteins that move substances across cellular membranes. The Boston company says drugs that focus on this family of proteins, called solute carrier (SLC) transporters, could address a […]

In this article